{
    "2021-08-18": [
        [
            {
                "time": "",
                "original_text": "美因基因赴港IPO：美年健康为大股东，8款在研产品尚未商业化",
                "features": {
                    "keywords": [
                        "美因基因",
                        "IPO",
                        "美年健康",
                        "在研产品",
                        "商业化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "基因检测赛道火热，美因基因借 IPO 能否继续长红？",
                "features": {
                    "keywords": [
                        "基因检测",
                        "赛道",
                        "IPO",
                        "长红"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "又一家民营医疗集团冲击上市！",
                "features": {
                    "keywords": [
                        "民营医疗",
                        "上市"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "美因基因递表港交所冲刺“国内基因检测第一股”集资3亿美元",
                "features": {
                    "keywords": [
                        "美因基因",
                        "港交所",
                        "基因检测",
                        "第一股",
                        "集资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "美因基因港交所递表：消费级基因检测是一门好生意了吗？",
                "features": {
                    "keywords": [
                        "美因基因",
                        "港交所",
                        "消费级基因检测",
                        "生意"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "每月检测基因23万次，中国最大癌症筛查平台要上市了",
                "features": {
                    "keywords": [
                        "基因检测",
                        "癌症筛查",
                        "平台",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测",
                        "癌症筛查"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}